INQOVI
Identification of Inqovi
| No description |
Google image searchProduct monograph
Active ingredients
decitabine, 35 MG
cedazuridine, 100 MG
DIN: 02501600
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: TAIHO PHARMA CANADA, INC.
Date: 26-JUL-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC58 — DECITABINE, COMBINATIONS (ATC/DDD)
